EBS·29089Q105·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
EBS (EMERGENT BIOSOLUTIONS INC) is held by 98 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($36M), STATE STREET CORP ($23.7M), DIMENSIONAL FUND ADVISORS LP ($22.9M). Net institutional sentiment: Mixed.
See how EBS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer